Similar articles

• Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.

  Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Caldwell RW. Caldwell RB, et al. Diabetes Metab Res Rev. 2003 Nov-Dec;19(6):442-55. doi: 10.1002/dmrr.415. Diabetes Metab Res Rev. 2003. PMID: 14648803 Review.
• [Granulocyte-macrophage colony-stimulating factor].

  Kimura F. Kimura F. Nihon Rinsho. 2005 Aug;63 Suppl 8:51-3. Nihon Rinsho. 2005. PMID: 16149449 Review. Japanese. No abstract available.
• [Basic fibroblast growth factor (bFGF/FGF-2) in urine].

  Ishiwata T, Naito Z. Ishiwata T, et al. Nihon Rinsho. 2005 Aug;63 Suppl 8:768-70. Nihon Rinsho. 2005. PMID: 16149636 Review. Japanese. No abstract available.
• [Soluble tumor necrosis factor receptor I, II].

  Takemura M, Saito K, Seishima M. Takemura M, et al. Nihon Rinsho. 2005 Aug;63 Suppl 8:158-60. Nihon Rinsho. 2005. PMID: 16149477 Review. Japanese. No abstract available.
• Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer.

  Kinnunen K, Korpisalo P, Rissanen TT, Heikura T, Viita H, Uusitalo H, Ylä-Herttuala S. Kinnunen K, et al. Acta Physiol (Oxf). 2006 Aug;187(4):447-57. doi: 10.1111/j.1748-1716.2006.01588.x. Acta Physiol (Oxf). 2006. PMID: 16866776